Clinical updates on diagnosing glutensensitive enteropathy


  • Faruk Hadziselimovic Institute for diagnosing coeliac disease Liestal, Kindertagesklinik, Liestal
  • Annemarie Bürgin-Wolff Institute for diagnosing coeliac disease Liestal


Coeliac disease, Antibodies, Intestinal biopsy, Diagnosis


In the last twenty years serology for the diagnosis of coeliac disease hasimproved substantially. As the result of our serological studies in 1998we proposed a gentle, low-risk, and cost eff ective algorithm for diagnosingvarious forms of gluten sensitive enteropathy, using a combinationof diff erent antibody determinations, namely IgA Endomysiumantibodies (EMA), Tissue-transglutaminase antibodies (IgA anti tTG,IgG anti tTG), IgA-and IgG antigliadin-antibodies. Performing routinelyserologic testing contributes to a decreased rate of endoscopicinterventions and improves the quality of the patient’s life.


Download data is not yet available.


Dickson B.C, Streutker CJ, Chetty R. Coeliac disease: an update for pathologists Review. Journal of clinical pathology. 2006;59:1008-16.

Celiac Disease Clinical Guideline JPGN. 2005;40:1-9.

NIH Consensus Statement on Celiac Disease. NIH Consens State Sci Statements. 2004 Jun 28-30; 21(1)1-22.

Kukainen K, Peraaho M, Collin P, Partanen J, Woollwy N, Kaartinen T, et al. Small bowel mucosal transglutaminase 2-specifi c IgA deposits in celiac disease without villous atrophy: a prospective and randomized study Scand J Gastroenerol.


Goldstein NS, Underhill J. Morphologic features suggestive of gluten sensitive architecturally normal duodenal biopsy specimens. AJCP. 2001;116:63-71.

Collin P, Kaukinen K, Vogelsang H, Korponay-Szabo I, Sommer R, Schreier E, et al. Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis if coeliac disease: a biopsy-proven European multicenter study Eur J Gastroenerol Hepatol. 2005;17(1):85-91.

Lembcke B, Schneider H, Lankisch PG. How safe is small bowel biopsy? Endoscopy. 1986;18(3):80-3.

Hadziselimovic F, Bürgin-Wolff A. Coeliac disease Lancet. 1998;351:9095:62-3.

Bürgin-Wolff A, Hadziselimovic F. Screening test for coeliac disease. Lancet. 1997;349:(9068):1843-4.

Bürgin-Wolff A, Dahlbom I, Hadziselimovic F, Petersson CJ. Antibodies ageinst human tissue transglutaminase and endomysium in diagnosing and monitoring coeliac disease Scand J Gastroenterol. 2002;37(6):685-91.

Bürgin-Wolff A, Gaze H, Hadziselimovic F, Huber H, Lentze M, Nussle D, et al. Antigliadin and antiendomysium antibody determination for coeliac disease Arch Dis Child. 1991;66(8):941-7.

Valdimarsson T, Franzen L, Grodzinsky E, Skoh T, Ström M. Is small bowel biopsy necessary in adults with suspected celiac disease and IgA antiendomysium antibodies? 100% positive predictive value for celiac disease in adults. Digestive Disease

and Sciences. 1996;14(1)83-7.

Mulder CJJ, Cellier C. Coeliac disease: changing views. Best Practice and Research Clinical Gastroenterology. 2005;19:(3)313-21.

Rostami K, Kerckheart J, Tiemessen R, von Blomberg BM, Meijr JW, Mulder CJ. Sensitivity of anti-endomysium and anti-gliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol. 1999;94:(9):888-94.

Mulder C, Rostami K, Marsh MN. When is a coeliac a coeliac? Gut. 1998;42(4):594.




How to Cite

Hadziselimovic, F., & Bürgin-Wolff, A. (2011). Clinical updates on diagnosing glutensensitive enteropathy. Acta Medica Academica, 40(2), 105–109. Retrieved from